No Data
No Data
New TTM went up and down in the intraday period, up 20.05%, and the turnover exceeded 35.63 million yuan.
New TTM went up and down in the intraday period, up 20.05%, and the turnover exceeded 35.63 million yuan.
Express News | New TTM: The issuance of non-standard reservations on financial statements does not touch upon mandatory financial delisting
New TTM (300518.SZ) announced first-quarter results, changing profit to loss to $62.463 million
New TTM (300518.SZ) released its report for the first quarter of 2024. The company's revenue was 43.3855 million yuan, a year-on-year decrease of 63.33%. The net loss attributable to shareholders of the listed company was 62.4603 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring profit and loss was $347.44,600. The basic loss per share was $0.31.
The e-commerce sector strengthened. Kaichun shares rose more than 6%, Xinhuadu rose nearly 4%, and Xinghui shares, Xinxunda, and Huakai eBay followed suit.
The e-commerce sector strengthened. Kaichun shares rose more than 6%, Xinhuadu rose nearly 4%, and Xinghui shares, Xinxunda, and Huakai eBay followed suit.
New TTM Shandong invests in the establishment of a new biotechnology company
According to the enterprise research app, recently, Shandong Tianyi Hongda Biotechnology Co., Ltd. was established. The legal representative is Yan Ming, with a registered capital of 100 million yuan. The business scope includes: bio-based material technology research and development; biochemical product technology research and development; bio-based material manufacturing, etc. The company's equity penetration revealed that the company is wholly owned by Guangxi Tianyi Hongda Biotechnology Co., Ltd., a subsidiary of Xinxindar.
Express News | New TTM: Focus on the new energy sector and have already entered the hydrogen energy sector
No Data